Literature DB >> 12604720

Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma.

Makoto Ishikawa1, Joji Kitayama, Shinsuke Kazama, Hirokazu Nagawa.   

Abstract

BACKGROUND: Vascular endothelial growth factor C (VEGF-C) and D (VEGF-D) are considered to be potentially lymphangiogenic and can selectively induce hyperplasia of the lymphatic vasculature. In this study, we aimed to clarify the relation between expression of VEGF-C and -D and lymphatic metastasis in early gastric cancers.
METHODS: Using the specific antibodies, we classified 105 cases which were treated as gastrectomy with standard lymphadenectomy at the First Department of Surgery, Tokyo University Hospital, between 1994 and 2001, into three groups (diffuse type, focal type and negative type) for VEGF-C and two groups (positive and negative) for VEGF-D.
RESULTS: There was a significant correlation between the expression of VEGF-C and -D and lymphatic invasion but not with venous invasion. All of the 22 cases that were negative for VEGF-C and -D were histologically classified as adenocarcinoma of undifferentiated type and showed negative lymph node metastasis and also negative lymphatic invasion. VEGF-C was positive in all tumors of differentiated type, while its expression varied in tumors of undifferentiated type. The VEGF-D positive rate is much lower than that of VEGF-C. In undifferentiated tumors in particular, VEGF-D was positive only in 4/64 (6%) and three of these four had nodal metastasis. Therefore, in tumors of differentiated type, expression of VEGF-C and -D had no clinical relevance. In tumors of undifferentiated type, the negative expression of VEGF-C suggests lack of nodal metastasis, while the positive expression of VEGF-D suggests nodal metastasis. The lymph node metastasis was significantly related to the expression of VEGF-C and -D in adenocarcinomas of undifferentiated type but not in those of differentiated tumors.
CONCLUSIONS: In early gastric cancers of histologically undifferentiated type with negative expression of VEGF-C and -D, limited surgery might be safely applied because the possibility of nodal metastasis is very low. These observations are based only on retrospective analysis of a small case series and further evaluation with a larger number of cases is necessary.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604720     DOI: 10.1093/jjco/hyg008

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  20 in total

1.  Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma.

Authors:  Atsuo Shida; Shuichi Fujioka; Katsutoshi Kobayashi; Yoshio Ishibashi; Hiroshi Nimura; Norio Mitsumori; Katsuhiko Yanaga
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

2.  Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinoma.

Authors:  Rui Zhao; Yuan Chang; Zhao Liu; Yanfeng Liu; Sen Guo; Jian Yu; Jiayong Wang
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

3.  Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endo; Kayoko Tabata; Taiichi Kawamura; Hyo-Yung Yun; Etsurou Bandou; Takuma Sasaki; Masahiro Miura
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

4.  Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".

Authors:  Da-zhi Sun; Jian-peng Jiao; Da-wei Ju; Min Ye; Xuan Zhang; Jing-yu Xu; Ye Lu; Jin He; Pin-kang Wei; Ming-hui Yang
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

5.  Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.

Authors:  Ge Lou; Ying Gao; Xiao-Ming Ning; Qi-Fan Zhang
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

6.  Prognostic significance of vascular endothelial growth factor D in gastric carcinoma.

Authors:  Atsuo Shida; Shuichi Fujioka; Yoshio Ishibashi; Katsutoshi Kobayashi; Hiroshi Nimura; Norio Mitsumori; Yutaka Suzuki; Makio Kawakami; Mitsuyoshi Urashima; Katsuhiko Yanaga
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

7.  Effect of Weikangning on gastric cancer cell growth and expression of vascular endothelial growth factor and its receptors KDR and Flt-1.

Authors:  Qing-Ming Li; Fang-Ju Kan; Cun-Yun Min
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Expression and significance of VEGF-C and FLT-4 in gastric cancer.

Authors:  Xing-E Liu; Xiao-Dong Sun; Jin-Min Wu
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

9.  Pathobiological significance of vascular endothelial growth factor and Maspin expressions in human gastric carcinoma.

Authors:  Jian-Jun Li; Ying Chen; Su-Min Zhang; Dong-Ying Wu; Yan-Ping Wang; Yan Xin
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

Review 10.  Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

Authors:  Theodore D Tsirlis; George Papastratis; Kyriaki Masselou; Christos Tsigris; Antonis Papachristodoulou; Alkiviadis Kostakis; Nikolaos I Nikiteas
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.